Methylation patterns in serum DNA for early identification of disseminated breast cancer

scientific article published on 22 December 2017

Methylation patterns in serum DNA for early identification of disseminated breast cancer is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1099894478
P356DOI10.1186/S13073-017-0499-9
P932PMC publication ID5740791
P698PubMed publication ID29268762

P50authorUsha MenonQ55130377
Martin WidschwendterQ71025350
Wolfgang JanniQ87697935
Brigitte RackQ114328175
Aleksandra Gentry-MaharajQ30001996
Timo WittenbergerQ50288613
P2093author name stringAllison Jones
Andy Ryan
David Cibula
Michal Zikan
Johannes Eichner
Marianna Alunni-Fabbroni
Julian Koch
Harri Lempiäinen
Tobias Paprotka
Benjamin Wahl
Daniel Reisel
Iona Evans
Shohreh Ghazali
P2860cites workMonitoring of Serum DNA Methylation as an Early Independent Marker of Response and Survival in Metastatic Breast Cancer: TBCRC 005 Prospective Biomarker StudyQ50860920
Genetic heterogeneity of single disseminated tumour cells in minimal residual cancer.Q52032203
Mechanism of early dissemination and metastasis in Her2+ mammary cancer.Q52813194
The benefits and harms of breast cancer screening: an independent reviewQ57131263
Erratum: Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patientsQ57280718
Outcome of primary-breast-cancer patients with micrometastases: a long-term follow-up studyQ78044311
DNA methylation in serum of breast cancer patients: an independent prognostic markerQ79317164
Prognostic DNA methylation marker in serum of cancer patientsQ80337161
A decade of exploring the cancer epigenome - biological and translational implicationsQ24614467
Methylated circulating tumor DNA in blood: power in cancer prognosis and responseQ26772077
Global cancer statistics, 2012Q27860501
Two-sided confidence intervals for the single proportion: comparison of seven methodsQ28271313
Influence of Computer-Aided Detection on Performance of Screening MammographyQ29540997
Analysis of circulating tumor DNA to monitor metastatic breast cancerQ29614797
Detection of circulating tumor DNA in early- and late-stage human malignanciesQ29615778
Circulating tumor cells, disease progression, and survival in metastatic breast cancerQ29619276
Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNAQ29620083
Plasma DNA tissue mapping by genome-wide methylation sequencing for noninvasive prenatal, cancer, and transplantation assessmentsQ30667824
Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial.Q30724410
Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient dataQ30779447
Preparation of reduced representation bisulfite sequencing libraries for genome-scale DNA methylation profilingQ33848902
Circulating tumor cells predict survival in early average-to-high risk breast cancer patientsQ33958981
Breast-Cancer Tumor Size, Overdiagnosis, and Mammography Screening EffectivenessQ34542420
Novel methylated biomarkers and a robust assay to detect circulating tumor DNA in metastatic breast cancer.Q35082784
Analytical and Clinical Validation of a Digital Sequencing Panel for Quantitative, Highly Accurate Evaluation of Cell-Free Circulating Tumor DNAQ35810461
Detection of somatic mutations and HPV in the saliva and plasma of patients with head and neck squamous cell carcinomasQ36104229
DNA methylation outliers in normal breast tissue identify field defects that are enriched in cancerQ36540420
Circulating free DNA in plasma or serum as biomarker of carcinogenesis: practical aspects and biological significanceQ36719984
Testing breast cancer serum biomarkers for early detection and prognosis in pre-diagnosis samples.Q37655098
DNA methylation markers for early detection of women's cancer: promise and challenges.Q38238828
Cell-free circulating tumour DNA as a liquid biopsy in breast cancerQ38699764
The Long and Short of Circulating Cell-Free DNA and the Ins and Outs of Molecular DiagnosticsQ38821212
Pooled Analysis of the Prognostic Relevance of Circulating Tumor Cells in Primary Breast CancerQ40142509
Comparative analysis of circulating tumor DNA stability In K3EDTA, Streck, and CellSave blood collection tubes.Q40370392
Improved reduced representation bisulfite sequencing for epigenomic profiling of clinical samplesQ41878991
Identification and characterisation of a platelet GPIb/V/IX-like complex on human breast cancers: implications for the metastatic processQ43777020
A pooled analysis of bone marrow micrometastasis in breast cancerQ44594123
Circulating tumor-specific DNA: a marker for monitoring efficacy of adjuvant therapy in cancer patientsQ45285546
Parallel progression of primary tumours and metastasesQ45831582
Circulating tumour cells in non-metastatic breast cancer: a prospective studyQ47652073
P433issue1
P304page(s)115
P577publication date2017-12-22
P1433published inGenome MedicineQ15816848
P1476titleMethylation patterns in serum DNA for early identification of disseminated breast cancer
P478volume9

Reverse relations

cites work (P2860)
Q89529508ADAM12 is A Potential Therapeutic Target Regulated by Hypomethylation in Triple-Negative Breast Cancer
Q57174700Are sleep continuity disturbance and fatigue prodromal symptoms of cancer development?
Q55435857DNA Methylation Patterns in Normal Tissue Correlate more Strongly with Breast Cancer Status than Copy-Number Variants.
Q61799424Epigenetic Biomarkers in Cell-Free DNA and Applications in Liquid Biopsy
Q91651645Perspectives of the Application of Liquid Biopsy in Colorectal Cancer
Q60046068Quantum Dot Based Nano-Biosensors for Detection of Circulating Cell Free miRNAs in Lung Carcinogenesis: From Biology to Clinical Translation
Q56524445The High-Throughput Analyses Era: Are We Ready for the Data Struggle?

Search more.